Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation-Reference-Cited by-同舟云学术

Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation

Published:2014-11-21 Issue:4 Volume:94 Page:663-669
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Brissot Eolia,Cahu Xavier,Guillaume Thierry,Delaunay Jacques,Ayari Sameh,Peterlin Pierre,Le Bourgeois Amandine,Harousseau Jean-Luc,Milpied Noel,Bene Marie-Christine,Moreau Philippe,Mohty Mohamad,Chevallier Patrice

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2259-x.pdf

Reference40 articles.

1. Neofytos D, Horn D, Anaissie E et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48(3):265–273

2. Fukuda T, Boeckh M, Carter RA et al (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102(3):827–833

3. Omer AK, Ziakas PD, Anagnostou T et al (2013) Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transplant 19(8):1190–1196

4. Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50(8):1091–1100

5. Kojima R, Kami M, Nannya Y et al (2004) Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen. Biol Blood Marrow Transplant 10(9):645–652

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxie des infections post-allogreffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2019-01

2. INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY;Mediterranean Journal of Hematology and Infectious Diseases;2018-07-01

3. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling;Transplant Infectious Disease;2018-05-16

4. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field;Expert Review of Anti-infective Therapy;2016-10-22